Physician profile
Brian M Roy
NPI 1528406659
$12,649.32
in general payments reported to CMS, 2019-2025
8 companies · $1,606 in 2025
The $1,606 reported for 2025 was more than what 97% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $2,233 · 2021: $70.97 · 2022: $3,547 · 2023: $1,430 · 2024: $2,591 · 2025: $1,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,290 · Food and Beverage: $1,246 · Education: $75.00 · Honoraria: $15.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,290.17 |
| Food and Beverage | $1,245.86 |
| Education | $75.00 |
| Honoraria | $15.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $8,160.13 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $3,232.98 | 2019-2021 | |
| Benco Dental Supply Co. | $907.03 | 2024 | |
| Salvin Dental Specialties, INC. | $227.97 | 2020 | |
| Straumann USA LLC | $58.49 | 2023-2024 | |
| Henry Schein, INC. | $29.54 | 2022 | |
| Align Technology, INC. | $18.71 | 2025 | Invisalign |
| Nobel Biocare USA | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.